Cardiology is the medical specialty focused on the heart and the cardiovascular system. It involves the diagnosis, treatment, and prevention of conditions affecting the heart and blood vessels. These conditions include coronary artery disease, heart failure, arrhythmias (irregular heartbeats), and valve disorders. The field covers a broad spectrum, from congenital heart defects present at birth to acquired conditions like heart attacks.
Send us all your questions or requests, and our expert team will assist you.
Cardiac amyloidosis is a condition that affects the heart muscle, making it stiff and less able to relax and fill with blood properly. It happens when an abnormal protein, called amyloid, builds up in the heart tissue. Think of the heart as a strong, flexible pump that squeezes blood out to the body and then relaxes to let new blood in. In this condition, the amyloid deposits act like starch in a piece of fabric, making the heart walls thick and rigid. This stiffness prevents the heart from expanding fully between beats, which means less blood can enter the heart to be pumped out. Over time, this can lead to fluid building up in the body and feelings of tiredness or shortness of breath.
Many people find the name of this condition difficult to pronounce and understand, but the concept is straightforward. It is essentially a storage problem where the body produces a protein that folds the wrong way and gets stuck in organs where it does not belong. While it was once considered rare, doctors are now finding it more often because diagnostic tools have improved significantly. It is important to know that this condition is not a form of cancer, nor is it caused by diet or lifestyle choices in the way that coronary artery disease is. It is a specific structural change in the heart muscle caused by these protein deposits. Understanding what cardiac amyloidosis is helps you and your family approach the diagnosis with clarity and calmness.
To understand this heart condition, it helps to understand the proteins involved. Proteins are the building blocks of the body, and they usually fold into specific shapes to do their jobs. Sometimes, the body produces proteins that are unstable or fold incorrectly. When these misfolded proteins clump together, they form rigid fibers called amyloid fibrils. These fibrils are very strong and resistant to being broken down by the body. They travel through the bloodstream and can settle in various organs.
When they settle in the heart, they take up space between the heart muscle cells. This process is gradual and can take years to develop. As more amyloid fibrils deposit in the heart, the heart muscle thickens. This thickening is different from the thickening seen in high blood pressure or athletes’ hearts. In those cases, the muscle cells themselves get bigger. In cardiac amyloidosis, the muscle cells are pushed apart by the foreign material. This distinction is key because it explains why standard heart medications often work differently for patients with this condition.
Proteins are like origami; they need to be folded perfectly to function. If a protein is made incorrectly due to a genetic error or age-related changes, it becomes unstable. Instead of staying in its correct shape, it unravels and sticks to other unravelled proteins. This sticky clump is what eventually forms the amyloid deposit. The body has trouble clearing these clumps away, so they accumulate over time.
The primary job of the heart is to pump blood. To do this efficiently, the heart must be elastic. It needs to stretch to accept blood and squeeze to push it out. The amyloid deposits make the heart walls stiff, like a leather boot instead of a rubber balloon. This stiffness means the heart has to work much harder to fill with blood. The pressure inside the heart goes up, which can cause fluid to leak into the lungs and legs.
There are several types of amyloidosis, but when it comes to the heart, two main types account for the vast majority of cases. Knowing which type a person has is the most critical step in determining the best care plan, as the treatments for each are completely different. The first type is related to an abnormality in bone marrow cells, and the second type is related to a protein made in the liver.
Light chain amyloidosis, often shortened to AL, is the type associated with bone marrow. In this form, the plasma cells in the bone marrow produce too many antibody fragments called light chains. These light chains misfold and deposit in the heart, kidneys, and nerves. This type tends to progress more quickly and requires urgent attention. The second type involves a protein called transthyretin. This protein normally carries vitamin A and thyroid hormone in the blood. When this protein becomes unstable, it forms deposits in the heart. This type is often commonly seen in older adults or runs in families.
This type is caused by a problem in the factory of the blood cells, the bone marrow. The plasma cells, which normally make antibodies to fight infection, start making abnormal light chains. These chains are toxic to the heart muscle cells and also cause stiffening. Because this type can affect the heart rapidly, doctors treat it with therapies that stop the production of these light chains quickly. It is often managed similarly to a blood disorder.
This type involves the transthyretin protein, which is made in the liver. There are two subtypes of ATTR. One is hereditary, meaning it is caused by a genetic mutation passed down from parents. The other is wild-type, which occurs simply as a result of aging, where the protein becomes unstable over time without a genetic mutation. Wild-type used to be called senile systemic amyloidosis, but that name is no longer used. This form progresses more slowly than AL amyloidosis.
Understanding the difference between wild-type and hereditary forms of transthyretin amyloidosis is important for family members. Wild-type amyloidosis is the most common form of cardiac amyloidosis. It typically affects men over the age of 60, though women can get it too. In wild-type, the gene for the protein is normal, but the protein itself falls apart due to aging processes. It is a condition acquired later in life and is not passed down to children.
Hereditary amyloidosis, on the other hand, is caused by a mutation in the gene that makes transthyretin. This mutation makes the protein unstable from birth, although symptoms usually do not appear until middle age or later. Because it is genetic, there is a 50 percent chance of passing the mutation to each child. Specific genetic mutations are more common in certain populations, such as people of African descent or those with Portuguese or Irish ancestry. Identifying a hereditary cause prompts doctors to suggest screening for other family members.
Cardiac amyloidosis does not affect everyone equally, and certain groups are more likely to develop it than others. Age is the most significant factor, especially for the wild-type form. As people live longer, the prevalence of this condition increases. It is often found in people who have been treated for heart failure but have not improved with standard medications. It is also frequently seen in people who have a history of carpal tunnel syndrome, specifically if they needed surgery for it in both wrists years before heart symptoms appeared.
Gender also plays a role. Men are diagnosed with wild-type cardiac amyloidosis much more frequently than women. For hereditary forms, the risk depends on the specific genetic mutation carried by the family. It is also worth noting that this condition is often underdiagnosed. Many people may be told they have heart failure with preserved ejection fraction, a technical term meaning the heart squeezes well but relaxes poorly, without being tested for amyloidosis. Awareness is growing, and more people are being correctly identified earlier in their journey.
To visualize the change in the heart, imagine the walls of the main pumping chamber, the left ventricle. In a healthy heart, these walls are of a certain thickness that allows for optimal movement. In cardiac amyloidosis, these walls become significantly thicker. However, unlike the thickening from high blood pressure, where the muscle is strong, here the thickening is caused by the passive buildup of amyloid.
The atria, the upper chambers of the heart, also become enlarged and thickened. The septum, which is the wall separating the left and right sides of the heart, thickens as well. This widespread thickening gives the heart a distinct appearance on imaging tests, often described as a speckled pattern. The valves of the heart can also be affected, becoming thickened and less efficient. All these structural changes contribute to the heart’s inability to manage blood flow efficiently, leading to the symptoms patients experience.
For a long time, cardiac amyloidosis was thought to be extremely rare and untreatable. This led to it being overlooked in many patients. However, the landscape has changed dramatically in recent years. We now know it is much more common than previously thought, especially among older adults with heart failure. This shift in understanding has led to the development of new, non-invasive diagnostic tests that make finding the condition easier and safer.
More importantly, there are now effective treatments available that can slow down or stop the production of amyloid. This has transformed the condition from one that could only be managed with supportive care to one that can be actively treated. The outlook for patients diagnosed today is significantly better than it was even a decade ago. With early detection and the right care team, people with cardiac amyloidosis are living longer, better lives.
Send us all your questions or requests, and our expert team will assist you.
Amyloid is a protein that has folded incorrectly and formed clumps. These clumps are tough and fibrous. They build up in organs and stop them from working properly.
No, cardiac amyloidosis is not a form of cancer. It is a disease caused by protein buildup in the tissues. However, one type called AL amyloidosis is treated with medications similar to those used for some blood cancers.
Currently, there is no cure that removes all existing deposits completely. However, treatments can stop new deposits from forming and stabilize the condition. This allows the heart to function better for longer.
Gentle activity is usually encouraged to keep muscles strong. However, heavy exertion may not be well tolerated. It is important to discuss specific limits with a doctor.
Yes, depending on the type, it can affect nerves, kidneys, and the digestive tract. It is a systemic condition, meaning it can involve multiple systems. This is why a full evaluation is needed.
Many people with heart failure actually have cardiac amyloidosis. This is when bad proteins build up in the heart, causing damage. Is it heart disease?
Your Comparison List (you must select at least 2 packages)
